Improving diabetes technology access for Black children and young adults
GO TEAM INTERVENTION PROTOCOL: GLUCOSE OPTIMIZATION THROUGH TECHNOLOGY ASSISTED MANAGEMENT: Use of a Diabetes Dashboard and Community Health Worker to Decrease Disparities in Technology Use in Pediatric T1D
This study is testing a new app and support program to help Black children and young adults with type 1 diabetes better access and use diabetes technology.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 8 Years to 18 Years |
| Sex | All |
| Sponsor | Case Western Reserve University Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Trial ID | NCT06074458 on ClinicalTrials.gov |
What this trial studies
This study aims to address the disparities in the use of diabetes technologies among Black/African American children and young adults with type 1 diabetes. It evaluates the acceptance and usage of a new computer program for diabetes management, a smartphone app called Glucosano, and the support of a community health worker. The goal is to ensure equitable access to continuous glucose monitors and insulin delivery systems for this population. By focusing on these interventions, the study seeks to enhance diabetes management and reduce racial disparities in technology utilization.
Who should consider this trial
Good fit: Ideal candidates are non-Hispanic Black children and young adults diagnosed with type 1 diabetes who are willing to engage with diabetes technology.
Not a fit: Patients with type 2 diabetes or those currently using an automated insulin delivery system may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve access to diabetes management technologies for Black children and young adults, leading to better health outcomes.
How similar studies have performed: While there have been studies addressing diabetes technology disparities, this specific approach utilizing a community health worker and a tailored app is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-reported as Non-Hispanic Black * Clinical diagnosis of T1D requiring treatment with insulin at the time of consent * Not currently (within the past 3 months) using an automated insulin delivery system \\ * Willingness to wear a continuous glucose monitor for 10 days at 3 different time points, and willingness to consider use of a personal continuous glucose monitor Exclusion Criteria: * Clinical diagnosis of Type 2 or monogenic diabetes * Completed high school * Non-English speaking guardians * Automated insulin delivery system use within the past 3 months * Custody of children and family services
Where this trial is running
Cleveland, Ohio
- University Hospitals Cleveland Medical Center — Cleveland, Ohio, United States (Recruiting)
Study contacts
- Study coordinator: Sarah MacLeish, DO
- Email: sarah.macleish2@uhhospitals.org
- Phone: 216-844-3661
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.